Literature DB >> 6833797

Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers.

E Tabor, R H Purcell, W T London, R J Gerety.   

Abstract

The infectivity of three inocula (subtypes ayw, adr, and adw) of hepatitis B virus was evaluated by intravenous inoculation of 54 chimpanzees. End-point infectivity titers were 10(-7.5) (ayw), 10(-8.0) (adr), and 10(-7.0) (adw). In contrast, the end-point titers for detection of hepatitis B surface antigen by radioimmunoassay were 10(-4) (ayw), 10(-4) (adr), and 10(-5) (adw). The mean incubation period for infections transmitted by each dilution of each of the inocula was inversely proportional to the amount of infectious virus in the dilution, but substantial overlap was observed among proximate dilutions. The severity of hepatitis in the chimpanzees differed among the inocula, but it was unrelated to the amount of virus inoculated. Thus, conclusions about the infectivity of hepatitis B virus after inactivation based on titers of hepatitis B surface antigen or on the inverse relationship between the incubation period and the end-point infectivity titer must be made with caution.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833797     DOI: 10.1093/infdis/147.3.531

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  The chimpanzee model for hepatitis B virus infection.

Authors:  Stefan F Wieland
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

Review 2.  Exposure to hepatitis B: review of current concepts.

Authors:  F H Zimmerman; G P Wormser
Journal:  Bull N Y Acad Med       Date:  1989-09

Review 3.  Molecular biology of the hepatitis B virus for clinicians.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Vijay Veer; Runu Chakravarty
Journal:  J Clin Exp Hepatol       Date:  2012-10-18

Review 4.  Human immunodeficiency virus and hepatitis--implications for operating room personnel.

Authors:  S Colbert; G J Sheehan
Journal:  Ir J Med Sci       Date:  1995-01       Impact factor: 1.568

5.  Serological markers of hepatitis B virus and cytomegalovirus infections in Norwegians with coagulation factor defects.

Authors:  H Rollag; S A Evensen; S S Frøland; A Glomstein
Journal:  Blut       Date:  1990-02

6.  Long PCR and its application to hepatitis viruses: amplification of hepatitis A, hepatitis B, and hepatitis C virus genomes.

Authors:  R Tellier; J Bukh; S U Emerson; R H Miller; R H Purcell
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

Review 7.  Hepatitis B virus infection. Current concepts of chronicity and immunity.

Authors:  G N Vyas; H E Blum
Journal:  West J Med       Date:  1984-05

8.  Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen.

Authors:  N Ogata; L Ostberg; P H Ehrlich; D C Wong; R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen.

Authors:  W Stephan; A M Prince; B Brotman
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

10.  In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees.

Authors:  Se Ho Kim; Se Ho Kim; Han Kyu Oh; Chun Jeih Ryu; Song Yong Park; Hyo Jeong Hong
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.